Luca Cartegni

8.0k total citations · 3 hit papers
38 papers, 6.3k citations indexed

About

Luca Cartegni is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Luca Cartegni has authored 38 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Genetics. Recurrent topics in Luca Cartegni's work include RNA Research and Splicing (24 papers), RNA and protein synthesis mechanisms (9 papers) and RNA modifications and cancer (8 papers). Luca Cartegni is often cited by papers focused on RNA Research and Splicing (24 papers), RNA and protein synthesis mechanisms (9 papers) and RNA modifications and cancer (8 papers). Luca Cartegni collaborates with scholars based in United States, Italy and Israel. Luca Cartegni's co-authors include Adrian R. Krainer, Shern L. Chew, Hong‐Xiang Liu, Michael Q. Zhang, Elisa de Stanchina, Michelle L. Hastings, Fabio Cobianchi, Giuseppe Biamonti, Silvano Riva and John A. Calarco and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Luca Cartegni

37 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Listening to silence and understanding nonsense: exonic mutations that affect splicing

2002 1.7k citations Luca Cartegni, Shern L. Chew et al. Nature Reviews Genetics profile →
ESEfinder: a web resource to identify exonic splicing enhancers

2003 1.3k citations Luca Cartegni Nucleic Acids Research profile →
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1

2002 578 citations Luca Cartegni, Adrian R. Krainer Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Cartegni United States	27	5.2k	1.1k	913	412	301	38	6.3k
G.J.B. van Ommen Netherlands	37	3.3k 0.6×	639 0.6×	1.3k 1.4×	336 0.8×	288 1.0×	91	4.8k
Peter C. Scacheri United States	41	4.8k 0.9×	626 0.6×	1.0k 1.1×	937 2.3×	769 2.6×	80	6.5k
Nick Thomas United Kingdom	27	3.2k 0.6×	342 0.3×	1.3k 1.5×	285 0.7×	164 0.5×	41	4.6k
Tim M. Townes United States	45	5.7k 1.1×	1.5k 1.4×	1.4k 1.5×	439 1.1×	559 1.9×	96	8.0k
Benoı̂t Chabot Canada	52	8.1k 1.6×	539 0.5×	682 0.7×	834 2.0×	515 1.7×	123	9.7k
Gen Kondoh Japan	36	2.8k 0.5×	466 0.4×	855 0.9×	326 0.8×	563 1.9×	95	5.2k
Petra Moerer Netherlands	19	4.9k 0.9×	427 0.4×	1.2k 1.3×	501 1.2×	1.3k 4.4×	23	6.1k
Qi‐Long Ying United States	28	7.1k 1.4×	821 0.8×	1.1k 1.2×	549 1.3×	443 1.5×	64	8.3k
Jorge Laborda Spain	39	2.9k 0.6×	251 0.2×	925 1.0×	509 1.2×	496 1.6×	86	4.4k
Stefan J. White Netherlands	31	1.9k 0.4×	410 0.4×	1.3k 1.5×	203 0.5×	106 0.4×	76	3.3k

Countries citing papers authored by Luca Cartegni

Since Specialization

Citations

This map shows the geographic impact of Luca Cartegni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Cartegni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Cartegni more than expected).

Fields of papers citing papers by Luca Cartegni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Cartegni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Cartegni. The network helps show where Luca Cartegni may publish in the future.

Co-authorship network of co-authors of Luca Cartegni

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Cartegni. A scholar is included among the top collaborators of Luca Cartegni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Cartegni. Luca Cartegni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shan, et al.. (2022). Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models. International Journal of Molecular Sciences. 23(6). 3010–3010. 3 indexed citations

Xu, Jin, Zhigang Lu, Ankita Narayan, et al.. (2017). Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine. Journal of Clinical Investigation. 127(4). 1561–1573. 57 indexed citations

Park, Jeong Eun & Luca Cartegni. (2017). In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching Antisense Oligonucleotides. Methods in molecular biology. 1648. 39–52. 3 indexed citations

Xu, Jin, Zhigang Lu, Mingming Xu, et al.. (2014). A Heroin Addiction Severity-Associated Intronic Single Nucleotide Polymorphism Modulates Alternative Pre-mRNA Splicing of the Opioid Receptor Gene OPRM1 via hnRNPH Interactions. Journal of Neuroscience. 34(33). 11048–11066. 43 indexed citations

Vorlová, Sandra, Clare V. LeFave, Francine M. Jodelka, et al.. (2011). Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation. Molecular Cell. 43(6). 927–939. 109 indexed citations

Zammarchi, Francesca, Mariangela Morelli, Michele Menicagli, et al.. (2011). KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma. American Journal Of Pathology. 178(1). 361–372. 70 indexed citations

Breda, Laura, Dorothy A. Kleinert, Carla Casu, et al.. (2010). A preclinical approach for gene therapy of β‐thalassemia. Annals of the New York Academy of Sciences. 1202(1). 134–140. 19 indexed citations

Nielsen, Karsten, Suzette Sørensen, Luca Cartegni, et al.. (2007). Seemingly Neutral Polymorphic Variants May Confer Immunity to Splicing-Inactivating Mutations: A Synonymous SNP in Exon 5 of MCAD Protects from Deleterious Mutations in a Flanking Exonic Splicing Enhancer. The American Journal of Human Genetics. 80(3). 416–432. 117 indexed citations

Cartegni, Luca, Michelle L. Hastings, John A. Calarco, Elisa de Stanchina, & Adrian R. Krainer. (2005). Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2. The American Journal of Human Genetics. 78(1). 63–77. 240 indexed citations

10.

Cartegni, Luca & Adrian R. Krainer. (2003). Correction of disease-associated exon skipping by synthetic exon-specific activators. Nature Structural Biology. 10(2). 120–125. 240 indexed citations

11.

Cartegni, Luca. (2003). ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Research. 31(13). 3568–3571. 1263 indexed citations breakdown →

12.

Cartegni, Luca & Adrian R. Krainer. (2002). Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nature Genetics. 30(4). 377–384. 578 indexed citations breakdown →

13.

Fackenthal, James D., Luca Cartegni, Adrian R. Krainer, & Olufunmilayo I. Olopade. (2002). BRCA2 T2722R Is a Deleterious Allele That Causes Exon Skipping. The American Journal of Human Genetics. 71(3). 625–631. 80 indexed citations

14.

Dance, Geoffrey S.C., Mark P. Sowden, Luca Cartegni, et al.. (2002). Two Proteins Essential for Apolipoprotein B mRNA Editing Are Expressed from a Single Gene through Alternative Splicing. Journal of Biological Chemistry. 277(15). 12703–12709. 40 indexed citations

15.

Cartegni, Luca, Shern L. Chew, & Adrian R. Krainer. (2002). Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics. 3(4). 285–298. 1694 indexed citations breakdown →

16.

Liu, Hongxiang, Shern L. Chew, Luca Cartegni, Michael Q. Zhang, & Adrian R. Krainer. (2000). Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions. Molecular and Cellular Biology. 20(3). 1063–1071. 190 indexed citations

17.

Squarzoni, Stefano, Patrizia Sabatelli, Andrea Ognibene, et al.. (1998). Immunocytochemical detection of emerin within the nuclear matrix. Neuromuscular Disorders. 8(5). 338–344. 41 indexed citations

18.

Sabatelli, Patrizia, Stefano Squarzoni, Stefania Petrini, et al.. (1998). Oral exfoliative cytology for the non-invasive diagnosis in X-linked Emery–Dreifuss muscular dystrophy patients and carriers. Neuromuscular Disorders. 8(2). 67–71. 29 indexed citations

19.

Cartegni, Luca. (1997). Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy. Human Molecular Genetics. 6(13). 2257–2264. 114 indexed citations

20.

Mora, Marina, Luca Cartegni, Claudia Di Blasi, et al.. (1997). X‐linked emery‐dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample. Annals of Neurology. 42(2). 249–253. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact